correction: Frannk Carlucci takes 4.1% stake in Pluristem/part of 13.5 Mil in restricted shares
posted on
Jul 19, 2007 03:27PM
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place